Rockwell Medical shares surge 21.17% intraday as Q4 preliminary results exceed expectations with $18.6M revenue and 22% gross margin, up from 14% in Q3.

Rockwell Medical surged 21.17% intraday trading, as the company reported Q4 2025 preliminary financial results exceeding expectations. The company announced Q4 revenue of $18.6 million, a 22% gross margin (up from 14% in Q3), and full-year 2025 revenue growth to $69.5 million with enhanced profitability.